Please assess the completion status of the following clinical trial:

Trial Title: A Study of a Levonorgestrel-Releasing Intrauterine System for Long-Term, Reversible Contraception

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Healthy women requesting contraception~* 16-35 years old~* Cohort 36-45 years old~* Sexually active~Exclusion Criteria:~* Currently pregnant, pregnant within 4 weeks prior to study entry or planning pregnancy within 24 months of study entry~* Currently breastfeeding~* Current persistent, abnormal vaginal bleeding

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: 45 Years
- Healthy Volunteers: t

Study Arms:
- LNG20 (16-35 Year Olds) (Type: EXPERIMENTAL): LNG20 levonorgestrel-releasing intrauterine system in subjects 16-35 years of age
- Mirena (Type: ACTIVE_COMPARATOR): Levonorgestrel-releasing intrauterine system for contraception
- LNG20 (36-45 Year Olds) (Type: EXPERIMENTAL): LNG20 levonorgestrel-releasing intrauterine system in subjects 36-45 years of age

Based on this trial design, predict the completion outcome and termination type (if applicable).